{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:01:46Z","timestamp":1773421306261,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/s0002-9149(03)00965-2","type":"journal-article","created":{"date-parts":[[2003,11,12]],"date-time":"2003-11-12T06:45:21Z","timestamp":1068619521000},"page":"24-31","source":"Crossref","is-referenced-by-count":49,"special_numbering":"S2","title":["Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease"],"prefix":"10.1016","volume":"92","author":[{"given":"Cindy","family":"Grines","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor M","family":"Rubanyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal S","family":"Kleiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pran","family":"Marrott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew W","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9149(03)00965-2_BIB1","doi-asserted-by":"crossref","unstructured":"Management of stable angina pectoris: recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 1997;18:394\u2013413","DOI":"10.1093\/oxfordjournals.eurheartj.a015259"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/cvr\/27.5.785","article-title":"A model to assess interventions to improve collateral blood flow","volume":"27","author":"Unger","year":"1993","journal-title":"Cardiovasc Res"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nm0596-534","article-title":"Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart","volume":"2","author":"Giordano","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1172\/JCI117378","article-title":"Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts","volume":"94","author":"Harada","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB5","series-title":"Gene Transfer in the Cardiovascular System: Experimental Approaches and Therapeutic Implications","first-page":"307","article-title":"Angiogenesis and collateral formation","author":"Isner","year":"1997"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB6","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/hc1102.105595","article-title":"Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris","volume":"105","author":"Grines","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(99)04180-X","article-title":"Cardiovascular gene therapy","volume":"355","author":"Yl\u00e4-Herttuala","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0006-2952(98)00332-3","article-title":"Receptors mediating adenovirus attachment and internalization","volume":"57","author":"Bergelson","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB9","unstructured":"Intracoronary gene transfer of FGF-4 in \u201cameroid pig.\u201d Data on file, Berlex Laboratories, Richmond, California. Report No. A02852, January 22, 1998"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB10","series-title":"Adenoviruses as Gene Delivery Vectors","author":"Sandmair","year":"2000"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB11","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1161\/01.RES.71.6.1490","article-title":"Coronary collateral development in swine after coronary artery occlusion","volume":"71","author":"White","year":"1992","journal-title":"Circ Res"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB12","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1161\/01.CIR.82.5.1778","article-title":"Effect of long-term exercise on regional myocardial function and coronary collateral development after gradual coronary artery occlusion in pigs","volume":"82","author":"Roth","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB13","unstructured":"Ad5FGF-4 dose\u2013response study in ameroid pig. Data on file, Berlex Laboratories, Richmond, California. Report No. A02854, January 23, 1998"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB14","unstructured":"Chronic efficacy study following single administration of Ad5FGF-4. Data on file, Berlex Laboratories, Richmond, California. Report No. A02856, March 5, 2000"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB15","unstructured":"Effect of high anti-Ad5 antibody titer on the efficacy ofAd5FGF-4 in an ameroid model of myocardial ischemia. Data on file, Berlex Laboratories, Richmond, California. Report No. A02858, January 21, 2000"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB16","unstructured":"Systemic toxicology, distribution and expression following intracoronary or left ventricular administration of Ad5FGF-4 in swine. Data on file, Berlex Laboratories, Richmond, California. Report No. A02950, October 9, 2003"},{"key":"10.1016\/S0002-9149(03)00965-2_BIB17","doi-asserted-by":"crossref","unstructured":"Grines C, Watkins M, Mahmarian J, Iskandrian A, Rade J, Marrott P, Pratt C, Kleiman N. A randomized double blind placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol2003;42:1339\u20131347","DOI":"10.1016\/S0735-1097(03)00988-4"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914903009652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914903009652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T00:25:31Z","timestamp":1550363131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914903009652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0002914903009652"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9149(03)00965-2","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}